163 related articles for article (PubMed ID: 23360883)
1. Host genotype, intestinal microbiota and inflammatory disorders.
Olivares M; Laparra JM; Sanz Y
Br J Nutr; 2013 Jan; 109 Suppl 2():S76-80. PubMed ID: 23360883
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
Strober W; Asano N; Fuss I; Kitani A; Watanabe T
Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
[TBL] [Abstract][Full Text] [Related]
3. The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease.
Olivares M; Neef A; Castillejo G; Palma GD; Varea V; Capilla A; Palau F; Nova E; Marcos A; Polanco I; Ribes-Koninckx C; Ortigosa L; Izquierdo L; Sanz Y
Gut; 2015 Mar; 64(3):406-17. PubMed ID: 24939571
[TBL] [Abstract][Full Text] [Related]
4. Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both.
Dezsofi A; Szebeni B; Hermann CS; Kapitány A; Veres G; Sipka S; Körner A; Madácsy L; Korponay-Szabó I; Rajczy K; Arató A
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):283-7. PubMed ID: 18728522
[TBL] [Abstract][Full Text] [Related]
5. Nod2 is essential for temporal development of intestinal microbial communities.
Rehman A; Sina C; Gavrilova O; Häsler R; Ott S; Baines JF; Schreiber S; Rosenstiel P
Gut; 2011 Oct; 60(10):1354-62. PubMed ID: 21421666
[TBL] [Abstract][Full Text] [Related]
6. Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease.
Cucchiara S; Stronati L; Aloi M
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S64-6. PubMed ID: 22955361
[TBL] [Abstract][Full Text] [Related]
7. Expression of microbiota, Toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease.
Kalliomäki M; Satokari R; Lähteenoja H; Vähämiko S; Grönlund J; Routi T; Salminen S
J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):727-32. PubMed ID: 22134550
[TBL] [Abstract][Full Text] [Related]
8. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
Agius LM
J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
[TBL] [Abstract][Full Text] [Related]
9. The microbiota in inflammatory bowel disease: friend, bystander, and sometime-villain.
Shanahan F
Nutr Rev; 2012 Aug; 70 Suppl 1():S31-7. PubMed ID: 22861805
[TBL] [Abstract][Full Text] [Related]
10. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice.
Verdu EF; Huang X; Natividad J; Lu J; Blennerhassett PA; David CS; McKay DM; Murray JA
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G217-25. PubMed ID: 18006603
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide-binding-oligomerization domain proteins and toll-like receptors: sensors of the inflammatory bowel diseases' microbial environment.
Mueller T; Podolsky DK
Curr Opin Gastroenterol; 2005 Jul; 21(4):419-25. PubMed ID: 15930981
[TBL] [Abstract][Full Text] [Related]
12. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
Satokari R
Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
[TBL] [Abstract][Full Text] [Related]
13. Host-microbe interactions: the difficult yet peaceful coexistence of the microbiota and the intestinal mucosa.
Sánchez de Medina F; Ortega-González M; González-Pérez R; Capitán-Cañadas F; Martínez-Augustin O
Br J Nutr; 2013 Jan; 109 Suppl 2():S12-20. PubMed ID: 23360876
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, genes and inflammatory bowel diseases in childhood.
de Mesquita MB; Civitelli F; Levine A
Dig Liver Dis; 2008 Jan; 40(1):3-11. PubMed ID: 17997369
[TBL] [Abstract][Full Text] [Related]
15. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
Petermann I; Huebner C; Browning BL; Gearry RB; Barclay ML; Kennedy M; Roberts R; Shelling AN; Philpott M; Han DY; Ferguson LR
Hum Immunol; 2009 Jun; 70(6):440-6. PubMed ID: 19275920
[TBL] [Abstract][Full Text] [Related]
16. Mucin function in inflammatory bowel disease: an update.
Boltin D; Perets TT; Vilkin A; Niv Y
J Clin Gastroenterol; 2013 Feb; 47(2):106-11. PubMed ID: 23164684
[TBL] [Abstract][Full Text] [Related]
17. [Genotype-phenotype associations in inflammatory bowel disease].
Hagymási K; Tulassay Z
Orv Hetil; 2005 Aug; 146(34):1767-73. PubMed ID: 16184878
[TBL] [Abstract][Full Text] [Related]
18. Targeting the complex interactions between microbiota, host epithelial and immune cells in inflammatory bowel disease.
Hirata Y; Ihara S; Koike K
Pharmacol Res; 2016 Nov; 113(Pt A):574-584. PubMed ID: 27702681
[TBL] [Abstract][Full Text] [Related]
19. The importance of gut microbiota in mediating the effect of NOD2 defects in inflammatory bowel disease.
Rogler G
Gut; 2010 Feb; 59(2):153-4. PubMed ID: 20176638
[No Abstract] [Full Text] [Related]
20. Host genetics and environmental factors regulate ecological succession of the mouse colon tissue-associated microbiota.
Smith P; Siddharth J; Pearson R; Holway N; Shaxted M; Butler M; Clark N; Jamontt J; Watson RP; Sanmugalingam D; Parkinson SJ
PLoS One; 2012; 7(1):e30273. PubMed ID: 22272321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
